ROGARNCT07816640
Renal Oxygenation-Guided AKI Reduction Trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Notable Start date pushed from Sep 20, 2026 to Nov 20, 2026
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (10)
Show 5 moreShow less
Arms and interventions
Bilateral renal regional oxygen saturation will be continuously monitored and displayed to the designated anesthesiologist. A decrease of 10% or more from the corresponding side-specific baseline will trigger assessment of signal validity and a standardized, clinically individualized optimization process addressing volume status, perfusion pressure, cardiac output, heart rate, ventilation and oxygenation, and hemoglobin concentration. Responses after each intervention will be reassessed and recorded.
Bilateral renal regional oxygen saturation will be continuously recorded, but values and trends will be hidden from the anesthesia and surgical teams and will not be used to guide care. Participants will receive usual perioperative management according to current clinical practice and local standards.
Devices: INVOS 5100C regional oxygen saturation monitoring system
Other: RrSO2-guided perioperative management, Usual perioperative management
Sites
20 sites in 1 country